From: Mechanistic insights revealed by lipid profiling in monogenic insulin resistance syndromes
Controls | Insulin receptoropathies | Lipodystrophy | P value | |
---|---|---|---|---|
Gender | 15 F, 12 M | 6 F, 1 M | 12 F, 2 M | |
Age (years) | 39 ± 14 | 27 ± 11 | 36 ± 9 | 0.14 |
BMI (kg/m2) | 24.6 ± 2.6 | 23.2 ± 3.6 | 24.1 ± 2.4 | 0.50 |
Fat mass (kg) | 20.9 ± 8.5 | 22.6 ± 10.0 | 10.2 ± 5.0 | <0.01 |
Lean mass (kg) | 47.3 ± 10.8 | 34.2 ± 3.8 | 53.9 ± 10.7 | <0.01 |
Glucose (mmol/l) | 4.5 ± 0.5 | 4.7 ± 0.8 | 6.4 ± 2.7 | <0.01 |
Insulin (pmol/l) | 27 ± 20 | 419 ± 269 | 116 ± 65 | <0.01 |
Adiponectin (mg/l) | 6.4 ± 3.2 | 10.5 ± 7.9 | 2.9 ± 3.3 | <0.01 |
Leptin (μg/l) | 16.9 ± 22.1 | 16.1 ± 8.1 | 4.2 ± 3.0 | 0.24 |
Triglyceride (mmol/l) | 0.9 ± 0.4 | 1.0 ± 0.3 | 2.9 ± 2.3 | <0.01 |
HDL-cholesterol (mmol/l) | 1.5 ± 0.4 | 1.8 ± 0.4 | 0.9 ± 0.5 | <0.01 |